Condition: Plaque Psoriasis · Sponsor: Bristol-Myers Squibb
The purpose of this pediatric study is to evaluate the drug levels, efficacy and safety of Deucravacitinib in children and adolescent participants aged 4 to \<18 years with moderate to severe plaque psoriasis. This study includes two cohorts; Cohort 1 (age 12 to \<18 years) and Cohort 2 (age 4 to \<12 years), with two parts; for each cohort. Part A will evaluate the drug levels of BMS-986165 to enable selection of 2 dose levels to be studied in Part B. Part B will assess the efficacy and safety of two dose levels in children and adolescent participants with moderate to severe plaque psoriasis. The 5-year long-term extension (LTE) period will observe the long-term safety and tolerability of deucravacitinib in children and adolescent participants with psoriasis who have completed Parts A or B of the study.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Instituto de Neumonologia Y Dermatologia | Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina | Recruiting |
| Psoriahue | Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina | Recruiting |
| CONEXA Investigacion Clinica S.A. | Buenos Aires, Argentina | Recruiting |
| Centro de Investigaciones Metabólicas (CINME) | Buenos Aires, Argentina | Recruiting |
| Hospital Italiano de Buenos Aires | CABA, Argentina | Recruiting |
| Consultora Integral de Salud | Córdoba, Argentina | Recruiting |
| The Skin Hospital | Darlinghurst, New South Wales, Australia | Recruiting |
| Local Institution - 0002 | Westmead, New South Wales, Australia | Withdrawn |
| Queensland Children's Hospital | Brisbane, Queensland, Australia | Recruiting |
| Veracity Clinical Research | Woolloongabba, Queensland, Australia | Recruiting |
| Monash Health | Clayton, Victoria, Australia | Recruiting |
| Local Institution - 0001 | Melbourne, Victoria, Australia | Completed |
+ 51 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04772079